FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311732839> ?p ?o ?g. }

• W4311732839 abstract "Abstract Background Persons who use drugs (PWUD) admitted for serious infections face many challenges when long courses of intravenous (IV) antibiotics are recommended. OPTIONS-DC is a structured multidisciplinary care conference used to navigate some of these challenges with harm reduction principles to consider patient preferences, decrease length of stay when safe, and support successful completion of antibiotics1. We aimed to describe antibiotic course outcomes 4 years after implementation of OPTIONS-DC. Methods We conducted a retrospective review of patients who had an OPTIONS-DC from February 2018 to February 2022. Any PWUD diagnosed with a serious infection requiring &gt; 2 weeks of IV antibiotic treatment were eligible for an OPTIONS-DC. Data was collected via a REDCap database. R version 3.3.2 (R Core Team, 2016) was used for statistical analysis. Results 144 conferences were included, for 129 unique patients. The mean age was 39.4 with 56.3% being male. The most common infections were bacteremia (52.8%) endocarditis (36.1%), and osteomyelitis (47.9%) with a mean recommended treatment duration of 5.62 weeks (Table 1). 87 (60.4%) patients with any substance use initiated medication assisted therapy (MAT) during admission including 74.5% (79/106) of those with opioid use disorder. 112 (77.8%) antibiotic courses were completed with 71 (63.4%) completed outpatient. Of those who initiated or continued MAT during admission, 83 (74.1%) completed antibiotic therapy. Course completion was similar for those discharged home at 84% (21/25) or to a Skilled Nursing Facility (SNF) 81.8% (9/11). All 18 patients who received antibiotics via home infusion vendor and 17 (81%) via infusion center completed their course. 39 (39.8%) patients received long acting IV antibiotics and 23 (23.5%) received oral antibiotics to complete their course. Average out of hospital antibiotic days for those who completed their course were 30.5. Table 1.OPTIONS-DC Table 1Table 1.OPTIONS-DC Table 1 continued Conclusion The OPTIONS-DC model continues to be a useful tool by incorporating harm reduction principles and patient preferences for PWUD at our hospital. Our completion rate of 77.8% and outpatient completion rate of 63.4% are higher while the patient directed discharge rate of 8.3% is lower than what is generally reported in literature for this population2-5. Disclosures Monica K. Sikka, MD, F2G: Site research investigator." @default.
• W4311732839 created "2022-12-28" @default.
• W4311732839 creator A5015092331 @default.
• W4311732839 creator A5043056406 @default.
• W4311732839 creator A5063416099 @default.
• W4311732839 creator A5079553105 @default.
• W4311732839 creator A5084598213 @default.
• W4311732839 creator A5087769386 @default.
• W4311732839 creator A5090006029 @default.
• W4311732839 creator A5090274106 @default.
• W4311732839 date "2022-12-01" @default.
• W4311732839 modified "2023-09-27" @default.
• W4311732839 title "1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD" @default.
• W4311732839 doi "https://doi.org/10.1093/ofid/ofac492.1392" @default.
• W4311732839 hasPublicationYear "2022" @default.
• W4311732839 type Work @default.
• W4311732839 citedByCount "0" @default.
• W4311732839 crossrefType "journal-article" @default.
• W4311732839 hasAuthorship W4311732839A5015092331 @default.
• W4311732839 hasAuthorship W4311732839A5043056406 @default.
• W4311732839 hasAuthorship W4311732839A5063416099 @default.
• W4311732839 hasAuthorship W4311732839A5079553105 @default.
• W4311732839 hasAuthorship W4311732839A5084598213 @default.
• W4311732839 hasAuthorship W4311732839A5087769386 @default.
• W4311732839 hasAuthorship W4311732839A5090006029 @default.
• W4311732839 hasAuthorship W4311732839A5090274106 @default.
• W4311732839 hasBestOaLocation W43117328392 @default.
• W4311732839 hasConcept C194828623 @default.
• W4311732839 hasConcept C2779443120 @default.
• W4311732839 hasConcept C501593827 @default.
• W4311732839 hasConcept C71924100 @default.
• W4311732839 hasConcept C86803240 @default.
• W4311732839 hasConcept C89423630 @default.
• W4311732839 hasConceptScore W4311732839C194828623 @default.
• W4311732839 hasConceptScore W4311732839C2779443120 @default.
• W4311732839 hasConceptScore W4311732839C501593827 @default.
• W4311732839 hasConceptScore W4311732839C71924100 @default.
• W4311732839 hasConceptScore W4311732839C86803240 @default.
• W4311732839 hasConceptScore W4311732839C89423630 @default.
• W4311732839 hasIssue "Supplement_2" @default.
• W4311732839 hasLocation W43117328391 @default.
• W4311732839 hasLocation W43117328392 @default.
• W4311732839 hasOpenAccess W4311732839 @default.
• W4311732839 hasPrimaryLocation W43117328391 @default.
• W4311732839 hasRelatedWork W1989192497 @default.
• W4311732839 hasRelatedWork W2057628462 @default.
• W4311732839 hasRelatedWork W2069671689 @default.
• W4311732839 hasRelatedWork W2089016219 @default.
• W4311732839 hasRelatedWork W2274212671 @default.
• W4311732839 hasRelatedWork W2981389549 @default.
• W4311732839 hasRelatedWork W3029048378 @default.
• W4311732839 hasRelatedWork W4292236266 @default.
• W4311732839 hasRelatedWork W4300011530 @default.
• W4311732839 hasRelatedWork W4308844557 @default.
• W4311732839 hasVolume "9" @default.
• W4311732839 isParatext "false" @default.
• W4311732839 isRetracted "false" @default.
• W4311732839 workType "article" @default.